CAMRF (Camurus AB) OCF Margin %: 30.42% (As of Mar. 2026)


CAMRF Camurus AB CAMRF
79 GF Score
Price $54.00
GF Value $83.14
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Camurus AB OCF Margin %?

Camurus AB CAMRF -3.57% 79 OCF Margin % is 30.42% as of Mar. 2026. GuruFocus rates CAMRF with a GF Score™ of 79/100 and a GF Value™ of $83.14 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, Camurus AB ranks better than 93.64% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Camurus AB's Cash Flow from Operations for the three months ended in Mar. 2026 was $17.4 Mil. Camurus AB's Revenue for the three months ended in Mar. 2026 was $57.2 Mil. Therefore, Camurus AB's OCF Margin % for the quarter that ended in Mar. 2026 was 30.42%.

As of today, Camurus AB's current OCF Yield % is 3.09%.

The historical rank and industry rank for Camurus AB's OCF Margin % or its related term are showing as below:

CAMRF' s OCF Margin % Range Over the Past 10 Years
Min: -555.71   Med: -47.48   Max: 38.37
Current: 42.51

During the past 13 years, the highest OCF Margin % of Camurus AB was 38.37%. The lowest was -555.71%. And the median was -47.48%.

CAMRF's OCF Margin % is ranked better than
93.64% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs CAMRF: 42.51

Camurus AB OCF Margin % Related Terms

Camurus AB OCF Margin % Historical Data

* Premium members only.

The historical data trend for Camurus AB's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camurus AB OCF Margin % Chart

Camurus AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.88 10.58 35.35 20.78 38.37

Camurus AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.91 55.63 28.30 55.00 30.42

CAMRF vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Camurus AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Camurus AB OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Camurus AB's OCF Margin % falls into.


CAMRF
79GF Score
Camurus AB CAMRF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Camurus AB OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Camurus AB's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=93.539/243.759
=38.37 %

Camurus AB's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=17.406/57.217
=30.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 30.42% mean?
Camurus AB (CAMRF) has a OCF Margin % of 30.42% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Camurus AB and its competitors. According to the industry distribution chart, Camurus AB ranks #61 out of 959 companies in the Biotechnology industry, placing it in the top 6.4%.
Is Camurus AB's OCF Margin % too high?
Camurus AB's current OCF Margin % is 30.42%. Based on the distribution chart, Camurus AB ranks #61 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Camurus AB has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Camurus AB's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Camurus AB ranks #61 out of 959 companies for OCF Margin %. This places Camurus AB in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Camurus AB and its competitors. Camurus AB's current OCF Margin % is 30.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camurus AB stock overvalued right now?
Based on GuruFocus' analysis, Camurus AB (CAMRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $83.14, compared to a current price of $54.00 — trading 35% below its estimated fair value. The current OCF Margin % is 30.42%. Camurus AB's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Camurus AB (CAMRF), the current OCF Margin % is 30.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Camurus AB (CAMRF) Overvalued in 2026?

Based on GuruFocus' analysis, Camurus AB stock appears to be undervalued. The current stock price of $54.00 is trading 35% below its estimated GF Value™ of $83.14. GuruFocus considers Camurus AB to be Significantly Undervalued.

Key valuation signals for CAMRF:

  • OCF Margin %: 30.42%
  • GF Value™: $83.14 vs. price of $54.00 (35% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the CAMRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Camurus AB Business Description

Address Rydbergs torg 4, Lund, SWE, SE-224 84
Camurus AB is a science-led biopharmaceutical company focused on developing and commercializing long-acting medicines for the treatment of severe and chronic diseases. It has two approved products, including treatments for opioid dependence, and a development pipeline supported by its FluidCrystal technology. Its clinical pipeline includes product candidates for conditions such as pain, cancer, endocrine, and metabolic diseases, developed in-house and in collaboration with international pharmaceutical companies. Its pipeline programs include CAM2029 for acromegaly, gastroenteropancreatic neuroendocrine tumors, and polycystic liver disease; CAM2038 for chronic pain; CAM4072 for genetic obesity disorders; CAM2043 for Raynaud's phenomenon; CAM4071 for endocrine disorders, among others.
79GF Score

Get the complete analysis for CAMRF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$54.00
Price
$83.14
GF Value